Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HYperfractionated Radiation Therapy Versus Concurrent Chemoradiation for Head and Neck Cancer (HYTC): A Phase III Randomized Controlled Trial

NCT07801235 is registered in ClinicalTrials.gov with King Hussein Cancer Center as lead sponsor.

NCT NCT07801235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07801235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HYperfractionated Radiation Therapy Versus Concurrent Chemoradiation for Head and Neck Cancer (HYTC): A Phase III Randomized Controlled Trial
Lead sponsor
King Hussein Cancer Center
Phase
Not applicable
Overall status
Recruiting
Start date
August 20, 2026
Completion date
April 1, 2033
Enrollment
604 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck (hnscc)